Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded. [Operator instructions] I would now like to turn the call over to Mr. Peter ...

New Jersey-based Merck said Tuesday in a statement on the litigation. "The plaintiff's allegations have no merit, and we remain committed to vigorously defending against these claims in the ...

Dr. Yeh will oversee the continued clinical development of NGM Bio’s key programs, NGM120 for hyperemesis gravidarum and cancer cachexia, and ...

Julie Levinson Werner and Sandra Halbing of Lowenstein Sandler discuss current DEI-related practices among businesses and ...

Merck & Co has said building its cardiovascular medicines ... by 40.8 meters from baseline at week 24 when added to stable background therapy for PAH. Patients who received sotatercept also ...

Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the ...

If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities ...

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.

Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th.

Robert Davis; Chairman of the Board, President, Chief Executive Officer; Merck & Co Inc Caroline Litchfield ... Merck undertakes no obligation to publicly update any forward-looking statements.